Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

167.57 -3.77 (-2.20%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Disney To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Patient Monitoring Device Maker Masimo Contemplates Separation of Consumer Business As Activist Investor Seeks Expanded Board Presence
Politan Capital Management's Quentin Koffey prepares for a proxy battle, seeking additional Masimo Corporation board seats. With a 9% stake, Koffey aims to influence the $7.1 billion market value... 
Via Benzinga
Wall Street Set To Open Weak Lower As Tech Feels China Chill: Analyst Says Stay Bullish 'If And Until This Changes'
Major U.S. index futures edged lower on Monday, reflecting the cautious mood from last week’s close. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We are starting off the day with a breakdown of the biggest pre-market stock movers that traders need to know about on Monday morning. 
Via InvestorPlace
Recap: Masimo Q4 Earnings
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
Politan Nominates Two Independent Candidates for Masimo Board
From Politan Capital Management
Via Business Wire
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading. 
Via Benzinga
Topics Stocks
Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
A Preview Of Masimo's Earnings
Via Benzinga
Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
From Masimo Corporation
Via Business Wire
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Masimo Named One of Fast Company’s Most Innovative Companies in North America
From Masimo
Via Business Wire
Apple Watch 2.0? New Patents Hint At Expansion Beyond Health Tracking After Masimo Fiasco
Apple has been considering incorporating anemometers, bolometers, heat flux sensors, solar radiation sensors, thermometers, and water sensors into future iterations of the Apple Watch. 
Via Benzinga
Topics Intellectual Property
Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
From Masimo
Via Business Wire
Masimo to Present in 45th Annual Raymond James Institutional Investors Conference
From Masimo Corporation
Via Business Wire
Masimo Reports Fourth Quarter and Full-Year 2023 Financial Results
From Masimo Corporation
Via Business Wire
Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth
From Masimo
Via Business Wire
Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter
From Masimo
Via Business Wire
New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
From Masimo
Via Business Wire
Tim Cook Opens Up On Apple Watch Ban, Licensing Masimo' Tech: 'We're Focused On Appeal'
Apple CEO Tim Cook has confirmed the company's plan to appeal the ban on its Apple Watch imposed in a patent dispute with Masimo, stating they have no intention of settling and will focus on the... 
Via Benzinga
Topics Intellectual Property
What Wall Street Experts Are Saying About Apple Ahead Of Earnings
Bulls and bears divided on Apple ahead of 'likely not great' report. 
Via Talk Markets
Vision Pro Exceeds Expectations, Banned Apple Watch Feature Saves Teen And More: Top News In Appleverse This Week
From booking a majority of TSMC's initial 2nm chips capacity to rolling out an "Alternative App Store" model in the EU, Apple's moves were far-reaching. 
Via Benzinga
Tim Cook Says 'Thanks' After Banned Apple Watch Feature Saves Teen From Altitude Sickness
A teenager suffering from altitude sickness in Peru was saved using the blood oxygen detection feature on an Apple Watch, a function currently banned in the U.S. due to a patent dispute with Masimo... 
Via Benzinga
Topics Intellectual Property
Samsung To Reportedly Level Up Its Health Tech Game — Plans To Challenge Apple With Noninvasive Blood Sugar Monitoring
Samsung Electronics is stepping up its health tech game by developing noninvasive glucose and continuous blood pressure monitoring technology, challenging Apple and other tech giants in the health-care... 
Via Benzinga
Apple's Move To Remove Blood Oxygen Feature In US Watches May Affect Sleep Apnea Detection, Says Mark Gurman
Apple's removal of the blood oxygen tracking feature from its smartwatches could impact its future health-related capabilities, including sleep apnea detection, as highlighted by Mark Gurman. 
Via Benzinga
Apple Watch Sidesteps Looming Ban, Cupertino Giant Outshines Samsung In Sales, Tim Cook Shows BTS Of Vision Pro: This Week In Appleverse
From securing the pole position in global smartphone shipments to navigating tricky patent disputes, Apple was in the thick of news this week 
Via Benzinga
Topics Intellectual Property
Masimo CEO 'Wholeheartedly' Feels Apple Watch Users Are Better Off Without Blood Oxygen Monitoring Feature
"Pulse oximetry is not useful unless it is a continuous monitor. That happens during sleep," Kiani explained. 
Via Benzinga
Apple Watch Versions Minus Blood Oxygen Feature To Go On Sale In US As Cupertino Devises Way To Sidestep Looming Ban
Apple Inc. modifies its latest Apple Watch models for the U.S. market by removing the blood oxygen feature, in response to a pending ban due to an intellectual property dispute with Masimo... 
Via Benzinga
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.